Britain opens world's first stem-cell bank

POTTERS BAR, England — Britain opened the world’s first national stem cell bank Wednesday, hoping to establish a lead in promising but controversial therapies using the master cells from human tissues.

1. Don't miss these Health stories
   1. 
      Facebook is now fueling organ donations

      Becky Melton’s “friend” request to Jerry Wilde, a complete stranger in dire need of a new kidney, came with a photo and a gift. The texted photo: a picture of Melton, 28, holding a hand-drawn sign showing two kidneys and a message -- “We’re a match!

   2. Why you should smile at strangers
   3. Grill, drive, play: Doc's tips for Memorial Day safety
   4. Cheating guys more likely to die of a heart attack
   5. German doctors apologize for Holocaust horrors

“Stem cell research offers real promise for the treatment of currently incurable diseases. The bank will ensure that researchers can explore the enormous potential of this exciting science for the future benefit of patients,” said Professor Colin Blakemore, chief executive of the Medical Research Council.

The bank was set up at the National Institute for Biological Standards and Control at Potter’s Bar, 12 miles north of London. Its mission is to store, characterize and grow cells and distribute them to researchers around the world.

The first two human embryonic stem cell lines to be deposited in the bank were developed at King’s College London and the Center for Life in Newcastle, England.

Regulations on cloning and stem cell research vary across Europe and around the world. The most liberal rules apply in Britain, where scientists can apply for a license to create human embryos by cloning in order to extract stem cells.

Stem cells can potentially grow into any type of human tissue. Scientists believe they could potentially be used to treat a range of diseases. Stem cells can be found in adults, but scientists believe they may not be as versatile as those in embryos.

Extracting cells from embryos created by cloning using a cell from a patient would in theory ensure the cell transplant is a perfect match, averting rejection by the immune system.